[1]
abu-abeeleh, J., Tarawneh, S., Al-Horani, "Mohammad A.S.M., Abu Saleh, R.M., AlSraiheen, K., abu-abeeleh, M. and Abu Alghanam, T.S. 2015. SIMVASTATIN TREATMENT AMELIORATES DIABETIC TYPE 2 CONDITIONS THROUGH LOWERING THE CONCENTRATION OF PLASMA ICAM LEVELS. European Scientific Journal, ESJ. 11, 24 (Aug. 2015).